ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,554Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1456

$1.4M Total Retail Price of All Prescriptions

Rank: 49 out of 1456

1,300 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,300 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 1,300 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 19,321 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 1,445 1,117 1 2
AMLODIPINE BESYLATE 1,249 936 2 1
LISINOPRIL 865 587 3 3
OMEPRAZOLE 702 512 4 5
LEVOTHYROXINE SODIUM 690 499 5 4
METFORMIN HCL 634 386 6 8
HYDROCHLOROTHIAZIDE 623 442 7 10
PRAVASTATIN SODIUM 544 427 8 9
HYDROCODONE-ACETAMINOPHEN 514 313 S3 9 6
METOPROLOL SUCCINATE 512 331 10 19
ATORVASTATIN CALCIUM 503 417 11 11
CARVEDILOL 501 337 12 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 493 350 13 24
FUROSEMIDE 490 334 14 7
AMLODIPINE BESYLATE-BENAZEPRIL 432 357 15 61
ATENOLOL 394 261 16 18
BENAZEPRIL HCL 309 266 17 57
NEXIUM 307 192 18 23
METOPROLOL TARTRATE 306 212 19 12
GABAPENTIN 296 167 20 13
ZOLPIDEM TARTRATE 291 170 21 14
TRAMADOL HCL 287 234 22 17
POTASSIUM CHLORIDE 259 173 23 15
NIFEDIPINE ER 252 196 24 81
METFORMIN HCL ER 244 182 25 54
RANITIDINE HCL 241 143 26 27
CLOPIDOGREL 231 169 27 32
CLONIDINE HCL 216 113 28 39
FLUTICASONE PROPIONATE 203 125 29 28
WARFARIN SODIUM 202 138 30 21
MELOXICAM 196 142 31 30
TRIAMTERENE-HCTZ 196 157 31 49
CITALOPRAM HBR 189 130 33 22
LOSARTAN POTASSIUM 174 128 34 16
ALLOPURINOL 172 138 35 31
DOXAZOSIN MESYLATE 166 159 36 84
PROAIR HFA 163 79 37 69
DICLOFENAC SODIUM 160 115 38 95
ALENDRONATE SODIUM 155 117 39 36
CRESTOR 150 57 40 26
PLAVIX 149 119 41 46
KLOR-CON M20 148 100 42 51
AZITHROMYCIN 146 91 43 44
LANTUS SOLOSTAR 143 81 44 120
GLIMEPIRIDE 143 132 44 33
DONEPEZIL HCL 141 141 46 29
ADVAIR DISKUS 139 92 47 63
GLIPIZIDE 138 86 48 53
LOSARTAN-HYDROCHLOROTHIAZIDE 137 128 49 41
ATENOLOL-CHLORTHALIDONE 133 122 50 172
VYTORIN 132 113 51 175
PANTOPRAZOLE SODIUM 132 91 51 43
INSULIN SYRINGE 128 85 53 64
AMITRIPTYLINE HCL 126 92 R 54 70
TAMSULOSIN HCL 125 78 55 34
LANTUS 125 72 55 50
VENTOLIN HFA 125 72 55 121
TRAZODONE HCL 124 78 58 47
SERTRALINE HCL 121 87 59 25
IBUPROFEN 120 73 60 103
GLYBURIDE 119 65 R 61 94
FELODIPINE ER 118 86 62 150
HYDRALAZINE HCL 116 72 63 48
DIOVAN 114 104 64 35
SINGULAIR 113 72 65 83
PEN NEEDLE 112 73 66 131
MECLIZINE HCL 112 76 66 101
NOVOLOG 108 72 68 104
TRAMADOL HCL-ACETAMINOPHEN 107 73 69 139
ZETIA 104 68 70 71
DIOVAN HCT 104 93 70 59
CYCLOBENZAPRINE HCL 102 63 R 72 66
PREDNISONE 97 66 73 42
COMBIVENT 92 64 74 110
KLOR-CON 10 89 55 75 96
FLUOXETINE HCL 89 51 75 55
LEVOFLOXACIN 87 58 77 79
ACETAMINOPHEN-CODEINE 84 58 S3 78 174
VERAPAMIL ER 84 61 78 82
PROMETHAZINE HCL 83 50 R 80 77
GLIPIZIDE ER 82 58 81 86
GEMFIBROZIL 80 59 82 117
ROPINIROLE HCL 80 68 82 90
OXYBUTYNIN CHLORIDE 80 63 82 156
LIPITOR 76 64 85 76
NAMENDA 75 75 86 38
LEVOCETIRIZINE DIHYDROCHLORIDE 75 31 86 283
GLYBURIDE-METFORMIN HCL 74 65 R 88 119
BYSTOLIC 73 62 89 102
JANUVIA 71 43 90 68
NOVOLOG FLEXPEN 70 39 91 198
LABETALOL HCL 67 39 92 180
PROPRANOLOL HCL 66 45 93 143
PAROXETINE HCL 65 49 94 67
SPIRIVA 65 48 94 75
LOVASTATIN 65 59 94 40
BENAZEPRIL-HYDROCHLOROTHIAZIDE 64 51 97 177
GLIPIZIDE XL 63 44 98 134
HYDROXYZINE HCL 62 34 R 99 164
FINASTERIDE 62 60 99 110
MONTELUKAST SODIUM 62 39 99 135
TRICOR 59 32 102 92
LYRICA 59 30 102 91
EXFORGE 59 45 102 211
ISOSORBIDE MONONITRATE ER 59 50 102 60
CELEBREX 59 36 102 88
HYDROCODONE BIT-IBUPROFEN 58 34 S3 107 420
SYNTHROID 58 52 107 37
FENOFIBRATE 58 25 107 56
CIPROFLOXACIN HCL 56 41 110 58
CARISOPRODOL 56 19 R 110 80
SPIRONOLACTONE 56 33 110 73
BISOPROLOL-HYDROCHLOROTHIAZIDE 56 56 110 93
NIFEDIAC CC 55 54 114 272
SYMBICORT 55 43 114 157
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 22 116 107
MOMETASONE FUROATE 53 37 117 369
ENALAPRIL MALEATE 50 38 118 87
NAPROXEN 50 31 118 100
FLUCONAZOLE 50 19 118 148
RAMIPRIL 50 47 118 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.